ENTRY       D11294                      Drug
NAME        Vadastuximab (USAN/INN)
SEQUENCE    (Heavy chain)
            XVQLVQSGAE VKKPGASVKV SCKASGYTFT NYDINWVRQA PGQGLEWIGW IYPGDGSTKY
            NEKFKAKATL TADTSTSTAY MELRSLRSDD TAVYYCASGY EDAMDYWGQG TTVTVSSAST
            KGPSVFPLAP SSKSTSGGTA ALGCLVKDYF PEPVTVSWNS GALTSGVHTF PAVLQSSGLY
            SLSSVVTVPS SSLGTQTYIC NVNHKPSNTK VDKKVEPKSC DKTHTCPPCP APELLGGPCV
            FLFPPKPKDT LMISRTPEVT CVVVDVSHED PEVKFNWYVD GVEVHNAKTK PREEQYNSTY
            RVVSVLTVLH QDWLNGKEYK CKVSNKALPA PIEKTISKAK GQPREPQVYT LPPSRDELTK
            NQVSLTCLVK GFYPSDIAVE WESNGQPENN YKTTPPVLDS DGSFFLYSKL TVDKSRWQQG
            NVFSCSVMHE ALHNHYTQKS LSLSPGK
            (Light chain)
            DIQMTQSPSS LSASVGDRVT INCKASQDIN SYLSWFQQKP GKAPKTLIYR ANRLVDGVPS
            RFSGSGSGQD YTLTISSLQP EDFATYYCLQ YDEFPLTFGG GTKVEIKRTV AAPSVFIFPP
            SDEQLKSGTA SVVCLLNNFY PREAKVQWKV DNALQSGNSQ ESVTEQDSKD STYSLSSTLT
            LSKADYEKHK VYACEVTHQG LSSPVTKSFN RGEC
            (Disulfide bridge: H22-H96, H144-H200, H220-L214, H226-H'226, H229-H'229, H2611-H321, H367-H425, H'22-H'96, H'144-H'200, H'220-L'214, H'261-H'321, H'367-H'425, L23-L88, L134-L194, L'23-L'88, L'134-L'194)
  TYPE      Peptide
EFFICACY    Antineoplastic, Anti-CD33 antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of leukemia
TARGET      CD33 (SIGLEC3) [HSA:945] [KO:K06473]
  PATHWAY   hsa04640(945)  Hematopoietic cell lineage
BRITE       Target-based classification of drugs [BR:br08310]
             Cell surface molecules and ligands
              Cell adhesion molecules: Ig superfamiy
               SIGLEC family
                CD33 (SIGLEC3)
                 D11294  Vadastuximab (USAN/INN)
DBLINKS     CAS: 1436390-63-4
            PubChem: 384585272
///
